A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
Clinical trial NCT05040906 · UNKNOWN
Trial details
- NCT number
- NCT05040906
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2023-10-13
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.